Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Oncogenic RAS Enables DNA Damage- and p53-Dependent Differentiation of Acute Myeloid Leukemia Cells in Response to Chemotherapy.

Mona Meyer, Daniela Rübsamen, Robert K. Slany, Thomas Illmer, Kathleen Stabla, Petra Roth, Thorsten Stiewe, Martin Eilers, Andreas Neubauer

Blood (2009) 114 (22): 5040.

https://doi.org/10.1182/blood.V114.22.5040.5040

Published: 2009

Journal Articles

Compassionate use of sorafenib in FLT3-ITD–positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation

Stephan Metzelder, Ying Wang, Ellen Wollmer, Michael Wanzel, Sabine Teichler, Anuhar Chaturvedi, Martin Eilers, Erich Enghofer, Andreas Neubauer, Andreas Burchert

Blood (2009) 113 (26): 6567–6571.

https://doi.org/10.1182/blood-2009-03-208298

Published: 2009

Includes: Supplemental data

Journal Articles

Knockdown of the Nuclear Oncogene SKI Inhibits Flt3-ITD Induced Signaling in 32D - Flt3-ITD Cells.

Nicole M. Hagner, Andreas Burchert, MD, Martin Eilers, PhD, Andreas Neubauer, MD

Blood (2006) 108 (11): 4491.

https://doi.org/10.1182/blood.V108.11.4491.4491

Published: 2006

Journal Articles

Inhibition of Retinoic Acid Receptor Signaling by SKI in Acute Myeloid Leukemia.

Markus Ritter, MD, Magnus Samuelsson, Oliver Hartmann, Andreas Burchert, MD, Theo D. Kim, MD, Christian Thiede, MD, Micheal J. Hayman, Nobuhide Ueki, Martin Eilers, Andreas Neubauer, MD

Blood (2004) 104 (11): 1132.

https://doi.org/10.1182/blood.V104.11.1132.1132

Published: 2004

Journal Articles

Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2

Andreas Burchert, Dali Cai, Lorenz C. Hofbauer, Magnus K. R. Samuelsson, Emily P. Slater, Justus Duyster, Markus Ritter, Andreas Hochhaus, Rolf Müller, Martin Eilers, Manuel Schmidt, Andreas Neubauer

Blood (2004) 103 (9): 3480–3489.

https://doi.org/10.1182/blood-2003-08-2970

Published: 2004

Journal Articles

c- mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia

Matthias Ballmaier, Manuela Germeshausen, Harald Schulze, Klara Cherkaoui, Sabine Lang, Annika Gaudig, Stephanie Krukemeier, Martin Eilers, Gabriele Strauß, Karl Welte

Blood (2001) 97 (1): 139–146.

https://doi.org/10.1182/blood.V97.1.139

Published: 2001

NARROW

Oncogenic RAS Enables DNA Damage- and p53-Dependent Differentiation of Acute Myeloid Leukemia Cells in Response to Chemotherapy.

Compassionate use of sorafenib in FLT3-ITD–positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation

Knockdown of the Nuclear Oncogene SKI Inhibits Flt3-ITD Induced Signaling in 32D - Flt3-ITD Cells.

Inhibition of Retinoic Acid Receptor Signaling by SKI in Acute Myeloid Leukemia.

Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2

c- mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia

Email alerts

ASH Publications

American Society of Hematology

Oncogenic RAS Enables DNA Damage- and p53-Dependent Differentiation of Acute Myeloid Leukemia Cells in Response to Chemotherapy.

Compassionate use of sorafenib in FLT3-ITD–positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation

Knockdown of the Nuclear Oncogene SKI Inhibits Flt3-ITD Induced Signaling in 32D - Flt3-ITD Cells.

Inhibition of Retinoic Acid Receptor Signaling by SKI in Acute Myeloid Leukemia.

Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2

c- mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only